Climazolam (Ro21-3982) was introduced under licence as a veterinary medicine by the Swiss Pharmacutical company Gräub under the tradename Climasol. Climazolam is a benzodiazepine, specifically an imidazobenzodiazepine derivative developed by Hoffman-LaRoche. It is similar in structure to triazolam and diclazepam and is used in veterinary medicine for anesthetizing animals.
